REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection
Clinical trial NCT02565719 · COMPLETED
Trial details
- NCT number
- NCT02565719
- Sponsor
- Replicor Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2019-05-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.